Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
TELO Telomir Pharmaceuticals
- 4.300
- -0.250-5.49%
Close Jan 8 16:00 ET
- 4.300
- 0.0000.00%
Post 20:01 ET
127.32MMarket Cap-5.55P/E (TTM)
4.580High4.280Low91.32KVolume4.360Open4.550Pre Close397.15KTurnover0.52%Turnover RatioLossP/E (Static)29.61MShares20.72052wk High286.67P/B75.10MFloat Cap3.11052wk Low--Dividend TTM17.46MShs Float20.720Historical High--Div YieldTTM6.59%Amplitude3.110Historical Low4.349Avg Price1Lot Size
Telomir Pharmaceuticals News
Renovaro Names Nathen Fuentes as CFO
Telomir Pharmaceuticals Shares Are Trading Higher After the Company Announced Potentially Groundbreaking Findings From a Preclinical Progeria Lifespan Study.
Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
Express News | Telomir Pharmaceuticals: Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria
Express News | Telomir Pharmaceuticals Inc - to Submit Ind & Inad Application by Q4 2025, With Clinical Trials Planned for 2026
EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease
Express News | Telomir Pharmaceuticals Shares Down 12.57% at $4.45 in Premarket Trade; White Diamind Research Says It Has a Strong Sell Rating on the Stock
Express News | Telomir Pharmaceuticals Announced It Raised $1M In Equity Funding Through Starwood Trust
Telomir Pharmaceuticals Enters Into Stock Purchase Agreement
Telomir Pharmaceuticals Raises $1M At $7 Per Share In No-warrant, Restricted Common Stock Deal - Filing
Individual Investors Are Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) Biggest Owners and Were Rewarded After Market Cap Rose by US$75m Last Week
Why Is Telomir Pharmaceuticals Stock Trading Higher On Tuesday?
Sector Update: Health Care Stocks Climb Thursday Afternoon
Sector Update: Health Care
Telomir Pharmaceuticals Shares Are Trading Higher After the Company Announced Preclinical Results Confirming the Efficacy of Telomir-1.
Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study With Telomir-1
Telomir Pharma Shares Rise 4% After Anti-Aging Drug News
Telomir Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday
Telomir Pharmaceuticals Reaches US$198m Market Cap Benefiting Insider Stock Buying
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.